News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,050 Results
Type
Article (39663)
Company Profile (247)
Press Release (658140)
Multimedia
Podcasts (48)
Webinars (12)
Section
Business (204164)
Career Advice (2007)
Deals (35415)
Drug Delivery (95)
Drug Development (81054)
Employer Resources (172)
FDA (16183)
Job Trends (14853)
News (345191)
Policy (32532)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2555)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49426)
ALS (87)
Alzheimer's disease (1372)
Antibody-drug conjugate (ADC) (124)
Approvals (16184)
Artificial intelligence (246)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (67)
Brain cancer (26)
Breast cancer (271)
Cancer (2171)
Cardiovascular disease (171)
Career advice (1675)
Career pathing (30)
CAR-T (145)
Cell therapy (407)
Cervical cancer (19)
Clinical research (65922)
Collaboration (814)
Compensation (519)
Complete response letters (19)
COVID-19 (2584)
CRISPR (37)
C-suite (231)
Cystic fibrosis (100)
Data (2106)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (263)
Diagnostics (6358)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86442)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112108)
Executive appointments (706)
FDA (17396)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (742)
Gene editing (100)
Generative AI (19)
Gene therapy (288)
GLP-1 (703)
Government (4411)
Grass and pollen (4)
Guidances (52)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (28)
Infectious disease (2726)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (92)
Interviews (311)
IPO (16500)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (462)
Leadership (16)
Legal (7909)
Liver cancer (73)
Lung cancer (311)
Lymphoma (147)
Machine learning (6)
Management (58)
Manufacturing (295)
MASH (65)
Medical device (13361)
Medtech (13366)
Mergers & acquisitions (19443)
Metabolic disorders (669)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (27)
Neuroscience (1887)
NextGen: Class of 2025 (6512)
Non-profit (4478)
Northern California (2600)
Now hiring (39)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (105)
Peanut (46)
People (57256)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20534)
Phase II (29025)
Phase III (21633)
Pipeline (1139)
Policy (135)
Postmarket research (2563)
Preclinical (8698)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (374)
Real estate (5907)
Recruiting (65)
Regulatory (22236)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (128)
Series B (83)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2233)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (28)
United States (22471)
Vaccines (676)
Venture capitalists (41)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Today (18)
Last 7 days (644)
Last 30 days (2238)
Last 365 days (32694)
2025 (9861)
2024 (35221)
2023 (40076)
2022 (51179)
2021 (55714)
2020 (54087)
2019 (46539)
2018 (35021)
2017 (32113)
2016 (31485)
2015 (37563)
2014 (31323)
2013 (26350)
2012 (28578)
2011 (29266)
2010 (27336)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37810)
Australia (6180)
California (5933)
Canada (1969)
China (505)
Colorado (260)
Connecticut (266)
Delaware (139)
Europe (81167)
Florida (878)
Georgia (202)
Idaho (57)
Illinois (520)
India (25)
Indiana (305)
Iowa (11)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (871)
Massachusetts (4422)
Michigan (216)
Minnesota (384)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1684)
New Mexico (28)
New York (1688)
North Carolina (950)
North Dakota (7)
Northern California (2600)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1335)
Puerto Rico (11)
Rhode Island (32)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2233)
Tennessee (101)
Texas (879)
Utah (177)
Virginia (140)
Washington D.C. (61)
Washington State (543)
West Virginia (3)
Wisconsin (52)
698,050 Results for "symbiotix biotherapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotherapies Pavilion Back by Popular Demand at 2024 AABB Annual Meeting in Houston, Texas
The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce the return of the Biotherapies Pavilion at the 2024 AABB Annual Meeting, which will take place Oct. 19-22 in Houston, Texas.
June 25, 2024
·
2 min read
Press Releases
AABB Hosting Congressional Briefing to Highlight Importance of Transfusion Medicine and Biotherapies
January 17, 2025
·
1 min read
Press Releases
Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership
March 19, 2025
·
7 min read
BioMidwest
NMDP BioTherapies Introduces Enhanced Cellular Materials for Allogeneic Cell Therapy Development
NMDP BioTherapies ℠, formerly Be The Match BioTherapies unveiled substantial upgrades to its cellular starting material offerings, including incorporating a Drug Master File (DMF) with its rapid-delivery, standard GMP leukopak to simplify regulatory filings.
April 16, 2024
·
4 min read
AABB Releases New Resources and Initiatives For its Certified Advanced Biotherapies Professional (CABP) Program
The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce several new offerings as part of its Certified Advanced Biotherapies Professional (CABP)
May 9, 2024
·
2 min read
Genetown
Cambridge Biotherapies Expands Innovative Services with Ketamine Infusions for Opioid-Free Pain Management
Cambridge Biotherapies proudly announces the launch of Ketamine Infusions for Pain and Headache Management, now available at all locations.
May 22, 2024
·
3 min read
BioMidwest
NMDP BioTherapies To Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies
NMDP BioTherapies℠ (formerly known as Be The Match BioTherapies) will present a poster at this year’s International Society for Cell & Gene Therapy annual meeting in Vancouver, Canada (ISCT 2024 ) sharing results of a study of the impacts of delayed whole blood processing on the stability of infectious disease marker analytes during donor qualification for allogeneic cell therapies.
May 28, 2024
·
3 min read
Business
NMDP BioTherapies Appoints New President to Lead Next Phase in Life-Saving Therapy Development
NMDP BioTherapies℠, formerly Be The Match BioTherapies, announced that Tom Hochuli will serve as president, leading the organization into its promising future phase.
January 30, 2024
·
4 min read
Business
BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non-oncology indications, today announced a collaboration with NMDP BioTherapies℠ (formerly Be The Match BioTherapies), an organization offering solutions for companies developing and commercializing cell and gene therapies, to advance BlueSphere’s first clinical trial evaluating a novel cell therapy for patients with high-risk leukemias.
June 25, 2024
·
7 min read
Press Releases
NMDP BioTherapies℠ Relaunches Premium Services Supporting Autologous Cell Therapies
October 7, 2024
·
3 min read
1 of 69,805
Next
